The thing here is Matt has poured his life into this and I dont think he is going to sell at this time. if the revenue projections are correct they would see close to 5B in 2025. if that is even close I would not sell the company for anything less than 50B if I were him. the one issue is.... can he hold out until he gets that revenue stream. the stock price would obviously go up dramatically if that were to occur. I think matt wants to be another Pfizer... not sell to Pfizer. thoughts??